GT
GSK icon

Glenmede Trust’s GSK GSK Stock Holding History

Glenmede Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24
Closed -$15K – 1219
2020
Q4 		$15K Buy
+24
New +$1.1K ﹤0.01% 1159

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Glenmede Trust's GSK Position: Q2 2026 in Review

Glenmede Trust reduced its GSK (GSK) stake by 0.92% in Q2 2026, selling an estimated $22.8K and leaving 46,706 shares worth $2.45M. The position accounts for 0.01% of the portfolio, ranked #549.

Glenmede Trust first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $14.3M in Q3 2016. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Glenmede Trust held 46,706 shares of GSK worth $2.45M as of Q2 2026.
  • Glenmede Trust sold 432 GSK shares in Q2 2026, an estimated $22.8K.
  • GSK made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #549 holding.
  • Glenmede Trust first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
  • Glenmede Trust's GSK position peaked at $14.3M in Q3 2016.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.